Report - OFFICE OF CLINICAL PHARMACOLOGY REVIEW - for delayed-release oral suspension (to-be-marketed formulation) contains omeprazole magnesium. Based on the amount of omeprazole, there are

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form